However, VANCO treatment prevented autoimmunity (reduced plasma levels of anti-dsDNA, anti-cardiolipin, and IFNα) (Figure 1D), proteinuria (Figure 1B), and renal injury histological features (Figure S3), but also reduced the progressive increase in SBP induced by IMQ, by approximately −15 mmHg (Figure 1A). The gene discussed is IFNA1; the disease is Autoimmunity.